Iterum Therapeutics PLC (ITRM)

NASDAQ
Currency in USD
1.540
0.000(0.00%)
Closed
After Hours
1.599+0.059(+3.831%)
ITRM Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Day's Range
1.4701.610
52 wk Range
0.8083.020
Key Statistics
Edit
Prev. Close
1.54
Open
1.55
Day's Range
1.47-1.61
52 wk Range
0.808-3.02
Volume
537.43K
Average Vol. (3m)
3.05M
1-Year Change
-18.95%
Book Value / Share
-0.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ITRM Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
7.500
Upside
+387.01%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Iterum Therapeutics PLC Company Profile

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Compare ITRM to Peers and Sector

Metrics to compare
ITRM
Peers
Sector
Relationship
P/E Ratio
−1.4x−0.8x−0.6x
PEG Ratio
−0.060.000.00
Price / Book
−3.7x2.4x2.6x
Price / LTM Sales
-1.3x3.1x
Upside (Analyst Target)
387.0%243.4%54.6%
Fair Value Upside
Unlock8.1%7.7%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.500
(+387.01% Upside)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-0.24 / -0.175
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

1.700
HOLO
-6.59%
2.2800
KULR
-8.06%
1.3300
LPSN
-3.62%
0.8899
LITM
+1.14%
8.900
APLD
-0.89%

FAQ

What Is the Iterum Therapeutics (ITRM) Stock Price Today?

The Iterum Therapeutics stock price today is 1.54

What Stock Exchange Does Iterum Therapeutics Trade On?

Iterum Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Iterum Therapeutics?

The stock symbol for Iterum Therapeutics is "ITRM."

What Is the Iterum Therapeutics Market Cap?

As of today, Iterum Therapeutics market cap is 42.37M.

What is Iterum Therapeutics Earnings Per Share?

The Iterum Therapeutics EPS is -1.87.

What Is the Next Iterum Therapeutics Earnings Date?

Iterum Therapeutics will release its next earnings report on Mar 31, 2025.

From a Technical Analysis Perspective, Is ITRM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.